ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,742Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 59

$691K Total Retail Price of All Prescriptions

Rank: 15 out of 59

567 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

5% of this provider’s 10,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 762 644 1 3
HYDROCODONE-ACETAMINOPHEN 680 469 S3 2 5
AMLODIPINE BESYLATE 679 546 3 4
SIMVASTATIN 669 440 4 1
LISINOPRIL 525 382 5 2
PANTOPRAZOLE SODIUM 473 339 6 33
METFORMIN HCL 378 251 7 6
METOPROLOL TARTRATE 350 229 8 9
LOSARTAN POTASSIUM 324 257 9 19
GLYBURIDE-METFORMIN HCL 274 193 R 10 59
FUROSEMIDE 253 168 11 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 237 172 12 18
METOPROLOL SUCCINATE 219 154 13 12
HYDROCHLOROTHIAZIDE 215 139 14 11
AZITHROMYCIN 206 157 15 32
CLOPIDOGREL 201 160 16 35
GLYBURIDE 200 150 R 17 48
ZOLPIDEM TARTRATE 192 114 18 17
CITALOPRAM HBR 189 100 19 25
TRAMADOL HCL 171 129 20 10
PLAVIX 157 117 21 54
AMLODIPINE BESYLATE-BENAZEPRIL 155 125 22 61
OMEPRAZOLE 147 110 23 7
LOSARTAN-HYDROCHLOROTHIAZIDE 142 125 24 39
GABAPENTIN 132 37 25 13
NEXIUM 115 106 26 14
CYMBALTA 112 76 27 57
ENALAPRIL MALEATE 111 85 28 49
LYRICA 108 34 29 71
JANUVIA 108 99 29 45
LEVEMIR 103 79 31 106
MELOXICAM 100 57 32 26
SUBOXONE 98 13 33 183
CEFDINIR 96 67 34 142
INSULIN SYRINGE 95 65 35 67
TAMSULOSIN HCL 95 79 35 27
ATORVASTATIN CALCIUM 94 54 37 15
SERTRALINE HCL 94 72 37 22
CYCLOBENZAPRINE HCL 94 58 R 37 80
FENOFIBRATE 89 63 40 86
CLONIDINE HCL 86 52 41 55
ATENOLOL 84 62 42 28
QUETIAPINE FUMARATE 81 0 43 46
POTASSIUM CHLORIDE 81 68 43 16
PRAVASTATIN SODIUM 81 67 43 21
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 58 46 60
ALLOPURINOL 73 73 47 42
CRESTOR 70 48 48 23
EVISTA 70 64 48 91
LEVOFLOXACIN 68 50 50 84
NOVOLIN 70-30 68 36 50 108
TRAMADOL HCL-ACETAMINOPHEN 67 54 52 77
BENAZEPRIL HCL 67 50 52 96
PROAIR HFA 66 53 54 68
CIPROFLOXACIN HCL 66 53 54 36
NITROGLYCERIN PATCH 65 53 56 211
ALENDRONATE SODIUM 64 51 57 20
HYDRALAZINE HCL 63 25 58 98
VESICARE 63 58 58 216
CELEBREX 62 46 60 87
DONEPEZIL HCL 62 62 60 24
NOVOLOG 61 32 62 123
LANTUS 60 19 63 53
CLOTRIMAZOLE-BETAMETHASONE 59 47 64 172
MECLIZINE HCL 55 34 65 72
DIOVAN 55 48 65 38
ADVAIR DISKUS 53 40 67 58
TRAZODONE HCL 52 27 68 50
ISOSORBIDE MONONITRATE ER 50 25 69 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.